Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease

20 Mar 2014

Abstract excerpt

Blood-cell-free circulating micro-RNAs (miRNAs) have been proposed as potential accessible biomarkers for neurodegenerative diseases such as Parkinson's disease (PD). Here we analyzed the serum levels of 377 miRNAs in a discovery set of 10 idiopathic Parkinson's disease (IPD) patients, 10 PD patients carriers of the LRRK2 G2019S mutation (LRRK2 PD), and 10 controls by using real-time quantitative PCR-based TaqMan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Neurogenetic and Muscular Disorders Research
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24648008
DOI: 10.1002/jnr.23377

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's diseasePMID 24648008Read ↗

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease PathophysiologySemantic proximity Read ↗

Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's DiseaseSemantic proximity Read ↗

Identification of aberrant circulating mi RNA s in Parkinson's disease plasma samplesSemantic proximity Read ↗

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s DiseaseSemantic proximity Read ↗

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseSemantic proximity Read ↗

Cellular and Extracellular microRNA Dysregulation in LRRK2-Linked Parkinson’s DiseaseSemantic proximity Read ↗

Identification of a panel of five serum miRNAs as a biomarker for Parkinson's diseaseSemantic proximity Read ↗

Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease PatientsSemantic proximity Read ↗

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsSemantic proximity Read ↗

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s diseaseSemantic proximity Read ↗

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesSemantic proximity Read ↗

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.